| ETS2 |
ETS2: Protein C-ets-2 |
DUSP2 |
DUSP2, PAC1: Dual specificity protein phosphatase 2 |
0.848 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
SP140 |
SP140, LYSP100: Nuclear body protein SP140 |
0.848 |
Evidence |
|
| UBE2E1 |
UBE2E1, UBCH6: Ubiquitin-conjugating enzyme E2 E1 |
RNF4 |
RNF4, RES4-26: RING finger protein 4 |
0.848 |
Evidence |
|
| EFNA5 |
EFNA5, EPLG7, LERK7: Ephrin-A5 precursor |
ILK |
ILK, ILK1, ILK2: Integrin-linked protein kinase |
0.848 |
Evidence |
|
| ACTA1 |
ACTA1, ACTA: Actin, alpha skeletal muscle |
MYH2 |
MYH2, MYHSA2: Myosin-2 |
0.845 |
Evidence |
|
| MYH11 |
MYH11, KIAA0866: Myosin-11 |
ACTA2 |
ACTA2, ACTSA, GIG46, ACTVS: Actin, aortic smooth muscle |
0.845 |
Evidence |
|
| DLG1 |
IPI00218729 |
GRIN2B |
GRIN2B, NMDAR2B: Glutamate [NMDA] receptor subunit epsilon-2 precursor |
0.845 |
Evidence |
|
| SUMO2 |
SUMO2, SMT3B, SMT3H2: Small ubiquitin-related modifier 2 precursor |
HIPK2 |
HIPK2: Homeodomain-interacting protein kinase 2 |
0.845 |
Evidence |
|
| PLG |
PLG: Plasminogen precursor |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
0.845 |
Evidence |
|
| ACTG1 |
ACTB: Actin, cytoplasmic 1 |
TRAF6 |
TRAF6, RNF85: TNF receptor-associated factor 6 |
0.845 |
Evidence |
|
| PRKX |
PRKX, PKX1: Serine/threonine-protein kinase PRKX |
PCTK2 |
PCTK2: Serine/threonine-protein kinase PCTAIRE-2 |
0.845 |
Evidence |
|
| KCNJ6 |
KCNJ6, GIRK2, KATP2, KCNJ7: G protein-activated inward rectifier potassium chann |
DLG4 |
DLG4, PSD95: Disks large homolog 4 |
0.845 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
GRAP |
GRAP: GRB2-related adapter protein |
0.845 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
CNOT8 |
CNOT8, CALIF, POP2: CCR4-NOT transcription complex subunit 8 |
0.845 |
Evidence |
|
| NR2F1 |
NR2F1, EAR3, ERBAL3, TFCOUP1: COUP transcription factor 1 |
HIPK2 |
HIPK2: Homeodomain-interacting protein kinase 2 |
0.845 |
Evidence |
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
RIT1 |
RIT1, RIBB, RIT, ROC1: GTP-binding protein Rit1 |
0.845 |
Evidence |
|
| GADD45B |
GADD45B, MYD118: Growth arrest and DNA-damage-inducible protein GADD45 beta |
GADD45G |
GADD45G, CR6, DDIT2: Growth arrest and DNA-damage-inducible protein GADD45 gamma |
0.845 |
Evidence |
|
| RAB11FIP3 |
RAB11FIP3, KIAA0665: Rab11 family-interacting protein 3 |
RAB11FIP2 |
RAB11FIP2, KIAA0941: Rab11 family-interacting protein 2 |
0.845 |
Evidence |
|
| TRAF5 |
TRAF5, RNF84: TNF receptor-associated factor 5 |
ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
0.845 |
Evidence |
|
| ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
TPM3 |
TPM3: Tropomyosin alpha-3 chain |
0.845 |
Evidence |
|
| ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
PTK9 |
TWF1, PTK9: Twinfilin-1 |
0.845 |
Evidence |
|
| PSMC2 |
PSMC2, MSS1: 26S protease regulatory subunit 7 |
SYBL1 |
SYBL1: Synaptobrevin-like protein 1 |
0.845 |
Evidence |
|
| TNFSF15 |
TNFSF15, RP11-428F18.1-001, hCG_27396: TNF superfamily ligand TL1A |
TNFRSF10C |
TNFRSF10C, DCR1, UNQ321/PRO366, LIT, TRAILR3, TRID: Tumor necrosis factor recept |
0.845 |
Evidence |
|
| YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
JAK1 |
|
0.845 |
Evidence |
|
| SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.845 |
Evidence |
|